Xiang Liu

Title: Innovations in Molecular Imaging by Xiang Liu

Introduction

Xiang Liu is a notable inventor based in Harbin, China. He has made significant contributions to the field of molecular imaging, particularly in evaluating liver regeneration capacity after surgical procedures. His innovative approach has the potential to enhance clinical practices in liver surgery.

Latest Patents

Xiang Liu holds a patent for a molecular imaging method aimed at assessing liver regeneration capacity following the ALPPS operation. The patent outlines a comprehensive method that includes preparing a VX2 rabbit liver cancer model, performing ALPPS, synthesizing 18F-Fluoromethylcholine (18F-Methylcholine, 18F-FCH), and conducting PET/CT imaging along with data processing. This method is groundbreaking as it is the first to utilize 18F-FCH PET/CT to monitor the proliferative capacity of residual liver tissue. The technique provides valuable insights into liver regeneration ability, which is crucial for determining the optimal timing for subsequent surgical interventions.

Career Highlights

Xiang Liu is affiliated with Harbin Medical University, where he continues to advance research in molecular imaging and liver surgery. His work has garnered attention for its innovative approach and practical applications in clinical settings.

Collaborations

Xiang Liu collaborates with esteemed colleagues, including Xilin Sun and Zhen Quan, who contribute to his research endeavors. Their combined expertise enhances the quality and impact of their work in the field.

Conclusion

Xiang Liu's contributions to molecular imaging represent a significant advancement in evaluating liver regeneration. His innovative methods have the potential to improve surgical outcomes and patient care in liver operations.